KCI Biotech (SUZHOU) Inc. (KCI) _KCI Biotech (SUZHOU) Inc. (KCI)

Help the global research and development of new drugs and care for human health

Preclinical CRO Platform

Non-Tumor Pharmacology and Pha… Preclinical service platform

Pathogenic Microorganism Servi… Preclinical service platform

Tumor pharmacology and pharmac… Preclinical service platform

Pharmacokinetics & Early toxic… Preclinical service platform

Molecular Pharmacy Preclinical service platform

Pathology Platform Preclinical service platform

Medical imaging Platform Preclinical service platform

Cell biology Preclinical service platform

Medical Equipment Preclinical service platform

Micro-organism/Organoid Preclinical service platform

Laboratory Sharing Platform Preclinical service platform

About us

KCI Biotech (Suzhou) Inc. and its wholly owned subsidiary Jiangsu KMQ Biotech Inc. are dedicated to providing comprehensive preclinical drug discovery and development services to global pharmaceutical companies and research institutions. Our mission is to support the advancement of innovative therapies by offering an integrated and efficient drug research and development evaluation system.

We operate two state-of-the-art laboratory animal facilities in Suzhou and Nantong, each certified by the International Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)……

Learn more+